☆Avidity Partners Management LP
Quality Q
0.661
AUM ($M)
624
Positions
45
Turnover
0.19
Top-10 wt
82%
Herfindahl
0.157
History (qtrs)
6
Excess Return
—
AI Eval Run AI Eval
Holdings · 56 positions · portfolio value $624M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆DNTH funds › | DIANTHUS THERAPEUTICS INC | HOLD | — | 32.8% | -9.0% | 205.1 | 2,104,184 | +0 | 5 | — |
| ☆CGON funds › | CG ONCOLOGY INC | NEW | — | 15.9% | +15.9% | 99.4 | 1,398,948 | +1,398,948 | 1 | — |
| ☆ORKA funds › | ORUKA THERAPEUTICS INC | HOLD | — | 11.6% | -0.2% | 72.4 | 760,424 | +0 | 5 | — |
| ☆JBIO funds › | JADE BIOSCIENCES INC | ADD | — | 6.1% | -1.7% | 37.8 | 1,700,708 | +300,000 | 5 | — |
| ☆ELVN funds › | ENLIVEN THERAPEUTICS INC | ADD | — | 4.5% | +0.7% | 27.9 | 550,000 | +150,000 | 5 | — |
| ☆CATX funds › | PERSPECTIVE THERAPEUTICS INC | ADD | — | 3.4% | -1.9% | 21.5 | 6,299,999 | +250,000 | 5 | — |
| ☆AKTS funds › | AKTIS ONCOLOGY INC | ADD | — | 2.5% | +0.5% | 15.6 | 484,200 | +15,634 | 2 | — |
| ☆PVLA funds › | PALVELLA THERAPEUTICS INC NE | HOLD | — | 1.7% | -0.3% | 10.7 | 70,000 | +0 | 3 | — |
| ☆MOBI funds › | MOBIA MED INC | NEW | — | 1.7% | +1.7% | 10.7 | 798,282 | +798,282 | 1 | — |
| ☆RGEN funds › | REPLIGEN CORP | HOLD | — | 1.7% | -0.4% | 10.6 | 77,800 | +0 | 5 | — |
| ☆IMUX funds › | IMMUNIC INC | NEW | — | 1.6% | +1.6% | 10.3 | 669,941 | +669,941 | 1 | — |
| ☆SENS funds › | SENSEONICS HLDGS INC | NEW | — | 1.5% | +1.5% | 9.1 | 1,600,000 | +1,600,000 | 1 | — |
| ☆KPTI funds › | KARYOPHARM THERAPEUTICS INC | ADD | — | 1.4% | +0.6% | 9.0 | 924,487 | +460,746 | 5 | — |
| ☆TEVA funds › | TEVA PHARMACEUTICAL INDS LTD | HOLD | — | 1.1% | -0.5% | 6.8 | 200,000 | +0 | 5 | — |
| ☆DXCM funds › | DEXCOM INC | HOLD | — | 1.1% | -0.3% | 6.7 | 100,000 | +0 | 2 | — |
| ☆TEM funds › | TEMPUS AI INC | ADD | — | 1.0% | +0.2% | 6.1 | 105,000 | +40,000 | 2 | — |
| ☆MDT funds › | MEDTRONIC PLC | TRIM | — | 0.9% | -1.0% | 5.5 | 70,000 | -30,000 | 4 | — |
| ☆VIR funds › | VIR BIOTECHNOLOGY INC | TRIM | — | 0.8% | -0.6% | 5.3 | 519,300 | -100,000 | 2 | — |
| ☆GPCR funds › | STRUCTURE THERAPEUTICS INC | ADD | — | 0.8% | +0.4% | 5.3 | 98,000 | +50,000 | 2 | — |
| ☆EHC funds › | ENCOMPASS HEALTH CORP | HOLD | — | 0.7% | -0.3% | 4.2 | 42,000 | +0 | 5 | — |
| ☆TENX funds › | TENAX THERAPEUTICS INC | HOLD | — | 0.6% | -0.2% | 3.9 | 265,934 | +0 | 2 | — |
| ☆NVCT funds › | NUVECTIS PHARMA INC | NEW | — | 0.6% | +0.6% | 3.7 | 200,000 | +200,000 | 1 | — |
| ☆PODD funds › | INSULET CORP | ADD | — | 0.6% | +0.2% | 3.7 | 24,000 | +14,000 | 2 | — |
| ☆BSX funds › | BOSTON SCIENTIFIC CORP | ADD | — | 0.5% | -0.2% | 3.4 | 80,000 | +20,000 | 5 | — |
| ☆MSLE funds › | SATELLOS BIOSCIENCE INC | HOLD | — | 0.5% | -0.2% | 3.0 | 387,769 | +0 | 2 | — |
| ☆ALMR funds › | ALAMAR BIOSCIENCES INC | NEW | — | 0.5% | +0.5% | 3.0 | 110,000 | +110,000 | 1 | — |
| ☆CNTX funds › | CONTEXT THERAPEUTICS INC | HOLD | — | 0.4% | -2.2% | 2.8 | 4,998,267 | +0 | 5 | — |
| ☆GILD funds › | GILEAD SCIENCES INC | HOLD | — | 0.4% | -0.2% | 2.5 | 20,000 | +0 | 2 | — |
| ☆CRL funds › | CHARLES RIV LABS INTL INC | HOLD | — | 0.4% | -0.0% | 2.3 | 10,000 | +0 | 2 | — |
| ☆PHAT funds › | PHATHOM PHARMACEUTICALS INC | TRIM | — | 0.3% | -0.3% | 2.2 | 200,000 | -49,390 | 5 | — |
| ☆AVLN funds › | AVALYN PHARMACEUTICALS INC | NEW | — | 0.3% | +0.3% | 2.0 | 60,000 | +60,000 | 1 | — |
| ☆KLRA funds › | KAILERA THERAPEUTICS INC | NEW | — | 0.3% | +0.3% | 1.8 | 80,000 | +80,000 | 1 | — |
| ☆GMAB funds › | GENMAB A/S | HOLD | — | 0.2% | -0.1% | 1.4 | 50,000 | +0 | 5 | — |
| ☆NTLA funds › | INTELLIA THERAPEUTICS INC | HOLD | — | 0.2% | -0.0% | 1.3 | 75,000 | +0 | 2 | — |
| ☆CRVS funds › | CORVUS PHARMACEUTICALS INC | TRIM | — | 0.2% | -0.2% | 1.2 | 80,000 | -35,000 | 2 | — |
| ☆ODD funds › | ODDITY TECH LTD | HOLD | — | 0.2% | -0.1% | 1.1 | 70,000 | +0 | 2 | — |
| ☆SCYX funds › | SCYNEXIS INC | NEW | — | 0.2% | +0.2% | 1.1 | 260,206 | +260,206 | 1 | — |
| ☆EVMN funds › | EVOMMUNE INC | NEW | — | 0.2% | +0.2% | 1.0 | 75,000 | +75,000 | 1 | — |
| ☆ABT funds › | ABBOTT LABORATORIES | HOLD | — | 0.1% | -0.1% | 0.9 | 10,000 | +0 | 2 | — |
| ☆BBIO funds › | BRIDGEBIO PHARMA INC | HOLD | — | 0.1% | -0.0% | 0.7 | 10,000 | +0 | 2 | — |
| ☆PTON funds › | PELOTON INTERACTIVE INC | TRIM | — | 0.1% | -0.2% | 0.6 | 100,000 | -100,000 | 2 | — |
| ☆LEGN funds › | LEGEND BIOTECH CORP | HOLD | — | 0.1% | -0.0% | 0.4 | 15,000 | +0 | 2 | — |
| ☆BBOT funds › | BRIDGEBIO ONCOLOGY THERAPEUT | HOLD | — | 0.1% | -0.0% | 0.3 | 43,853 | +0 | 2 | — |
| ☆SVRA funds › | SAVARA INC | HOLD | — | 0.0% | -0.0% | 0.3 | 50,000 | +0 | 2 | — |
| ☆TRVI funds › | TREVI THERAPEUTICS INC | HOLD | — | 0.0% | -0.0% | 0.1 | 6,660 | +0 | 2 | — |
| ☆AVR funds › | ANTERIS TECHNOLOGIES GLOBAL | EXIT | — | 0.0% | -0.2% | 0.0 | 0 | -150,000 | 0 | — |
| ☆NTRA funds › | NATERA INC | EXIT | — | 0.0% | -0.4% | 0.0 | 0 | -9,000 | 0 | — |
| ☆ICLR funds › | ICON PLC | EXIT | — | 0.0% | -0.4% | 0.0 | 0 | -16,000 | 0 | — |
| ☆CUSIP:4525EP101 funds › | IMMUNIC INC | EXIT | — | 0.0% | -1.5% | 0.0 | 0 | -669,941 | 0 | — |
| ☆CORT funds › | CORCEPT THERAPEUTICS INC | EXIT | — | 0.0% | -0.3% | 0.0 | 0 | -30,000 | 0 | — |
| ☆ABUS funds › | ARBUTUS BIOPHARMA CORP | EXIT | — | 0.0% | -0.1% | 0.0 | 0 | -125,000 | 0 | — |
| ☆CUSIP:811292200 funds › | SCYNEXIS INC | EXIT | — | 0.0% | -0.4% | 0.0 | 0 | -2,081,660 | 0 | — |
| ☆ACAD funds › | ACADIA PHARMACEUTICALS INC | EXIT | — | 0.0% | -0.1% | 0.0 | 0 | -12,967 | 0 | — |
| ☆MLTX funds › | MOONLAKE IMMUNOTHERAPEUTICS | EXIT | — | 0.0% | -0.2% | 0.0 | 0 | -50,000 | 0 | — |
| ☆HUM funds › | HUMANA INC | EXIT | — | 0.0% | -1.3% | 0.0 | 0 | -25,000 | 0 | — |
| ☆HIMS funds › | HIMS & HERS HEALTH INC | EXIT | — | 0.0% | -0.3% | 0.0 | 0 | -50,000 | 0 | — |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 624 | 45 | 0.25 | 82% | 0.157 | 0.523 | — | in |
| 2026Q1 | 442 | 46 | 0.46 | 81% | 0.203 | 0.141 | — | in |
| 2025Q4 | 347 | 39 | 0.27 | 72% | 0.109 | 0.262 | — | in |
| 2025Q3 | 439 | 43 | 0.53 | 66% | 0.115 | 0.036 | — | in |
| 2025Q2 | 499 | 55 | 0.41 | 49% | 0.035 | 0.064 | — | entered |
| 2025Q1 | 485 | 63 | 0.00 | 44% | 0.030 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status